L Wu1, F A Petrigliano2, K Ba3, S Lee4, J Bogdanov5, D R McAllister6, J S Adams7, A K Rosenthal8, B Van Handel9, G M Crooks10, Y Lin11, D Evseenko12. 1. Department of Orthopaedic Surgery, Orthopedic Hospital Research Center, David Geffen School of Medicine (DGSOM), University of California at Los Angeles, Los Angeles, CA 90095, USA. Electronic address: lingwu@mednet.ucla.edu. 2. Department of Orthopaedic Surgery, Orthopedic Hospital Research Center, David Geffen School of Medicine (DGSOM), University of California at Los Angeles, Los Angeles, CA 90095, USA. Electronic address: FPetrigliano@mednet.ucla.edu. 3. Department of Orthopaedic Surgery, Orthopedic Hospital Research Center, David Geffen School of Medicine (DGSOM), University of California at Los Angeles, Los Angeles, CA 90095, USA; State Key Laboratory for Oral Diseases, West China School of Stomatology, Sichuan University, Chengdu, 610041, China. Electronic address: k.ba@msn.com. 4. Department of Orthopaedic Surgery, Orthopedic Hospital Research Center, David Geffen School of Medicine (DGSOM), University of California at Los Angeles, Los Angeles, CA 90095, USA. Electronic address: siyounglee@mednet.ucla.edu. 5. Department of Orthopaedic Surgery, Orthopedic Hospital Research Center, David Geffen School of Medicine (DGSOM), University of California at Los Angeles, Los Angeles, CA 90095, USA. Electronic address: j.bogdanov@ucla.edu. 6. Department of Orthopaedic Surgery, Orthopedic Hospital Research Center, David Geffen School of Medicine (DGSOM), University of California at Los Angeles, Los Angeles, CA 90095, USA. Electronic address: dmcallister@mednet.ucla.edu. 7. Department of Orthopaedic Surgery, Orthopedic Hospital Research Center, David Geffen School of Medicine (DGSOM), University of California at Los Angeles, Los Angeles, CA 90095, USA; UCLA Broad Stem Cell Institute for Regenerative Medicine and Stem Cell Research, USA; UCLA Jonsson Comprehensive Cancer Center, USA. Electronic address: JSAdams@mednet.ucla.edu. 8. Division of Rheumatology, Department of Medicine, Medical College of Wisconsin, 9200 West Wisconsin Avenue, Milwaukee WI 53226, USA. Electronic address: Ann.Rosenthal@va.gov. 9. Novogenix Laboratories, LLC, Los Angeles, CA 90033, USA. Electronic address: bvanhandel@novogenixlabs.com. 10. UCLA Broad Stem Cell Institute for Regenerative Medicine and Stem Cell Research, USA; UCLA Jonsson Comprehensive Cancer Center, USA; Department of Pathology and Laboratory Medicine, DGSOM, UCLA, USA. Electronic address: GCrooks@mednet.ucla.edu. 11. State Key Laboratory for Oral Diseases, West China School of Stomatology, Sichuan University, Chengdu, 610041, China. Electronic address: yunfenglin@scu.edu.cn. 12. Department of Orthopaedic Surgery, Orthopedic Hospital Research Center, David Geffen School of Medicine (DGSOM), University of California at Los Angeles, Los Angeles, CA 90095, USA; UCLA Broad Stem Cell Institute for Regenerative Medicine and Stem Cell Research, USA; UCLA Jonsson Comprehensive Cancer Center, USA. Electronic address: devseenko@mednet.ucla.edu.
Abstract
OBJECTIVE: Articular cartilage is a highly specialized tissue which forms the surfaces in synovial joints. Full-thickness cartilage defects caused by trauma or microfracture surgery heal via the formation of fibrotic tissue characterized by a high content of collagen I (COL I) and subsequent poor mechanical properties. The goal of this study is to investigate the molecular mechanisms underlying fibrosis after joint injury. DESIGN: Rat knee joint models were used to mimic cartilage defects after acute injury. Immunohistochemistry was performed to detect proteins related to fibrosis. Human fetal chondrocytes and bone marrow stromal cells (BMSCs) were used to study the influence of the lipid lysophosphatidic acid (LPA) on COL I synthesis. Quantitative PCR, ELISA and immunohistochemistry were performed to evaluate the production of COL I. Chemical inhibitors were used to block LPA signaling both in vitro and in vivo. RESULTS: After full-thickness cartilage injury in rat knee joints, stromal cells migrating to the injury expressed high levels of the LPA-producing enzyme autotaxin (ATX); intact articular cartilage in rat and humans expressed negligible levels of ATX despite expressing the LPA receptors LPAR1 and LPAR2. LPA-induced increases in COL I production by chondrocytes and BMSCs were mediated by the MAP kinase and PI3 Kinase signaling pathways. Inhibition of the ATX/LPA axis significantly reduced COL I-enriched fibrocartilage synthesis in full-thickness cartilage defects in rats in favor of the collagen II-enriched normal state. CONCLUSION: Taken together, these results identify an attractive target for intervention in reducing the progression of post-traumatic fibrosis and osteoarthritis.
OBJECTIVE:Articular cartilage is a highly specialized tissue which forms the surfaces in synovial joints. Full-thickness cartilage defects caused by trauma or microfracture surgery heal via the formation of fibrotic tissue characterized by a high content of collagen I (COL I) and subsequent poor mechanical properties. The goal of this study is to investigate the molecular mechanisms underlying fibrosis after joint injury. DESIGN:Rat knee joint models were used to mimic cartilage defects after acute injury. Immunohistochemistry was performed to detect proteins related to fibrosis. Human fetal chondrocytes and bone marrow stromal cells (BMSCs) were used to study the influence of the lipidlysophosphatidic acid (LPA) on COL I synthesis. Quantitative PCR, ELISA and immunohistochemistry were performed to evaluate the production of COL I. Chemical inhibitors were used to block LPA signaling both in vitro and in vivo. RESULTS: After full-thickness cartilage injury in rat knee joints, stromal cells migrating to the injury expressed high levels of the LPA-producing enzyme autotaxin (ATX); intact articular cartilage in rat and humans expressed negligible levels of ATX despite expressing the LPA receptors LPAR1 and LPAR2. LPA-induced increases in COL I production by chondrocytes and BMSCs were mediated by the MAP kinase and PI3 Kinase signaling pathways. Inhibition of the ATX/LPA axis significantly reduced COL I-enriched fibrocartilage synthesis in full-thickness cartilage defects in rats in favor of the collagen II-enriched normal state. CONCLUSION: Taken together, these results identify an attractive target for intervention in reducing the progression of post-traumatic fibrosis and osteoarthritis.
Authors: Chenqi Zhao; Maria J Fernandes; Glenn D Prestwich; Mélanie Turgeon; John Di Battista; Timothy Clair; Patrice E Poubelle; Sylvain G Bourgoin Journal: Mol Pharmacol Date: 2007-11-15 Impact factor: 4.436
Authors: Honglu Zhang; Xiaoyu Xu; Joanna Gajewiak; Ryoko Tsukahara; Yuko Fujiwara; Jianxiong Liu; James I Fells; Donna Perygin; Abby L Parrill; Gabor Tigyi; Glenn D Prestwich Journal: Cancer Res Date: 2009-06-09 Impact factor: 12.701
Authors: Jason P Zlotnicki; Andrew G Geeslin; Iain R Murray; Frank A Petrigliano; Robert F LaPrade; Barton J Mann; Volker Musahl Journal: Orthop J Sports Med Date: 2016-04-15
Authors: Gabriel B Ferguson; Ben Van Handel; Maxwell Bay; Petko Fiziev; Tonis Org; Siyoung Lee; Ruzanna Shkhyan; Nicholas W Banks; Mila Scheinberg; Ling Wu; Biagio Saitta; Joseph Elphingstone; A Noelle Larson; Scott M Riester; April D Pyle; Nicholas M Bernthal; Hanna Ka Mikkola; Jason Ernst; Andre J van Wijnen; Michael Bonaguidi; Denis Evseenko Journal: Nat Commun Date: 2018-09-07 Impact factor: 14.919
Authors: Lourdes Alcaide-Ruggiero; Verónica Molina-Hernández; María M Granados; Juan M Domínguez Journal: Int J Mol Sci Date: 2021-12-11 Impact factor: 5.923